{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:23:57Z","timestamp":1762079037206},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T00:00:00Z","timestamp":1208390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s12031-008-9062-x","type":"journal-article","created":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T12:17:45Z","timestamp":1208348265000},"page":"355-361","source":"Crossref","is-referenced-by-count":14,"title":["Adrenomedullin-2\/Intermedin Induces cAMP Accumulation in Dissociated Rat Spinal Cord Cells: Evidence for the Existence of a Distinct Class of Sites of Action"],"prefix":"10.1007","volume":"35","author":[{"given":"Ali Akbar","family":"Owji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Guy","family":"Chabot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvan","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9mi","family":"Quirion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,17]]},"reference":[{"key":"9062_CR1","first-page":"123","volume":"254","author":"T. Dennis","year":"1990","unstructured":"Dennis, T., Fournier, A., Cadieux, A., et al. (1990). hCGRP8\u201337, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. Journal of Pharmacology and Experimental Therapeutics, 254, 123\u2013128.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"9062_CR2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.bjp.0703110","volume":"129","author":"H. Doods","year":"2000","unstructured":"Doods, H., Hallermayer, G., Wu, D., et al. (2000). Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. British Journal of Pharmacology, 129, 420\u2013423.","journal-title":"British Journal of Pharmacology"},{"key":"9062_CR3","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.2983422","volume":"227","author":"D. Goltzman","year":"1985","unstructured":"Goltzman, D., & Mitchell, J. (1985). Interaction of calcitonin and calcitonin gene-related peptide at receptor sites in target tissues. Science, 227, 1343\u20131345.","journal-title":"Science"},{"key":"9062_CR4","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.peptides.2007.02.007","volume":"28","author":"H. Hashimoto","year":"2007","unstructured":"Hashimoto, H., Hyodo, S., Kawasaki, M., et al. (2007). Adrenomedullin 2 (AM2)\/intermedin is a more potent activator of hypothalamic oxytocin-secreting neurons than AM possibly through an unidentified receptor in rats. Peptides, 28, 1104\u20131112.","journal-title":"Peptides"},{"key":"9062_CR5","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1124\/mol.104.008615","volume":"67","author":"D. L. Hay","year":"2005","unstructured":"Hay, D. L., Christopoulos, G., Christopoulos, A., Poyner, D. R., & Sexton, P. M. (2005). Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. Molecular Pharmacology, 67, 1655\u20131665.","journal-title":"Molecular Pharmacology"},{"key":"9062_CR6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/JMN:22:1-2:105","volume":"22","author":"D. L. Hay","year":"2004","unstructured":"Hay, D. L., Conner, A. C., Howitt, S. G., Smith, D. M., & Poyner, D. R. (2004). The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors. Journal of Molecular Neuroscience, 22, 105\u2013113.","journal-title":"Journal of Molecular Neuroscience"},{"key":"9062_CR7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.bjp.0705472","volume":"140","author":"D. L. Hay","year":"2003","unstructured":"Hay, D. L., Howitt, S. G., Conner, A. C., Schindler, M., Smith, D. M., & Poyner, D. R. (2003). CL\/RAMP2 and CL\/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22\u201352, CGRP8\u201337 and BIBN4096BS. British Journal of Pharmacology, 140, 477\u2013486.","journal-title":"British Journal of Pharmacology"},{"key":"9062_CR8","first-page":"1084","volume":"258","author":"M. Mimeault","year":"1991","unstructured":"Mimeault, M., Fournier, A., Dumont, Y., St-Pierre, S., & Quirion, R. (1991). Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. Journal of Pharmacology and Experimental Therapeutics, 258, 1084\u20131090.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"9062_CR9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.peptides.2007.01.018","volume":"28","author":"R. Morimoto","year":"2007","unstructured":"Morimoto, R., Satoh, F., Murakami, O., et al. (2007). Expression of adrenomedullin2\/intermedin in human brain, heart, and kidney. Peptides, 28, 1095\u20131103.","journal-title":"Peptides"},{"key":"9062_CR10","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1046\/j.1471-4159.1996.67052172.x","volume":"67","author":"A. A. Owji","year":"1996","unstructured":"Owji, A. A., Gardiner, J. V., Upton, P. D., et al. (1996). Characterisation and molecular identification of adrenomedullin binding sites in the rat spinal cord: a comparison with calcitonin gene-related peptide receptors. Journal of Neurochemistry, 67, 2172\u20132179.","journal-title":"Journal of Neurochemistry"},{"key":"9062_CR11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1476-5381.1992.tb14272.x","volume":"105","author":"D. R. Poyner","year":"1992","unstructured":"Poyner, D. R., Andrew, D. P., Brown, D., Bose, C., & Hanley, M. R. (1992). Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes. British Journal of Pharmacology, 105, 441\u2013447.","journal-title":"British Journal of Pharmacology"},{"key":"9062_CR12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","volume":"54","author":"D. R. Poyner","year":"2002","unstructured":"Poyner, D. R., Sexton, P. M., Marshall, I., et al. (2002). International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacological Reviews, 54, 233\u2013246.","journal-title":"Pharmacological Reviews"},{"key":"9062_CR13","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1074\/jbc.M305332200","volume":"279","author":"J. Roh","year":"2004","unstructured":"Roh, J., Chang, C. L., Bhalla, A., Klein, C., & Hsu, S. Y. (2004). Intermedin is a calcitonin\/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor\/receptor activity-modifying protein receptor complexes. Journal of Biological Chemistry, 279, 7264\u20137274.","journal-title":"Journal of Biological Chemistry"},{"key":"9062_CR14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1042\/bst0300432","volume":"30","author":"D. M. Smith","year":"2002","unstructured":"Smith, D. M., Coppock, H. A., Withers, D. J., et al. (2002). Adrenomedullin: receptor and signal transduction. Biochemical Society Transactions, 30, 432\u2013437.","journal-title":"Biochemical Society Transactions"},{"key":"9062_CR15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-5793(03)01368-1","volume":"556","author":"Y. Takei","year":"2004","unstructured":"Takei, Y., Inoue, K., Ogoshi, M., Kawahara, T., Bannai, H., & Miyano, S. (2004). Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Letters, 556, 53\u201358.","journal-title":"FEBS Letters"},{"key":"9062_CR16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/sj.bjp.0706750","volume":"148","author":"M. A. Takhshid","year":"2006","unstructured":"Takhshid, M. A., Poyner, D. R., Chabot, J. G., et al. (2006). Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture. British Journal of Pharmacology, 148, 459\u2013468.","journal-title":"British Journal of Pharmacology"},{"key":"9062_CR17","doi-asserted-by":"crossref","first-page":"R919","DOI":"10.1152\/ajpregu.00744.2004","volume":"288","author":"M. M. Taylor","year":"2005","unstructured":"Taylor, M. M., Bagley, S. L., & Samson, W. K. (2005). Intermedin\/adrenomedullin-2 acts within central nervous system to elevate blood pressure and inhibit food and water intake. American Journal of Physiology. Regulatory Integrative and Comparative Physiology, 288, R919\u2013R927.","journal-title":"American Journal of Physiology. Regulatory Integrative and Comparative Physiology"},{"key":"9062_CR18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1210\/en.2005-0949","volume":"147","author":"M. M. Taylor","year":"2006","unstructured":"Taylor, M. M., Bagley, S. L., & Samson, W. K. (2006). Intermedin\/adrenomedullin-2 inhibits growth hormone release from cultured, primary anterior pituitary cells. Endocrinology, 147, 859\u2013864.","journal-title":"Endocrinology"},{"key":"9062_CR19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-7634(96)00023-1","volume":"21","author":"D. Rossum van","year":"1997","unstructured":"van Rossum, D., Hanisch, U. K., & Quirion, R. (1997). Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neuroscience and Biobehavioral Reviews, 21, 649\u2013678.","journal-title":"Neuroscience and Biobehavioral Reviews"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-008-9062-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-008-9062-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-008-9062-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:19:16Z","timestamp":1559427556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-008-9062-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,17]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["9062"],"URL":"https:\/\/doi.org\/10.1007\/s12031-008-9062-x","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,17]]}}}